These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 17559367)

  • 1. Norfloxacin and trimethoprim-sulfamethoxazole therapy have similar efficacy in prevention of spontaneous bacterial peritonitis.
    Lontos S; Gow PJ; Vaughan RB; Angus PW
    J Gastroenterol Hepatol; 2008 Feb; 23(2):252-5. PubMed ID: 17559367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin.
    Novella M; Solà R; Soriano G; Andreu M; Gana J; Ortiz J; Coll S; Sàbat M; Vila MC; Guarner C; Vilardell F
    Hepatology; 1997 Mar; 25(3):532-6. PubMed ID: 9049193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized controlled study of trimethoprim-sulfamethoxazole versus norfloxacin for the prevention of infection in cirrhotic patients.
    Lontos S; Shelton E; Angus PW; Vaughan R; Roberts SK; Gordon A; Gow PJ
    J Dig Dis; 2014 May; 15(5):260-7. PubMed ID: 24612987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addition of probiotics to norfloxacin does not improve efficacy in the prevention of spontaneous bacterial peritonitis: a double-blind placebo-controlled randomized-controlled trial.
    Pande C; Kumar A; Sarin SK
    Eur J Gastroenterol Hepatol; 2012 Jul; 24(7):831-9. PubMed ID: 22522141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage.
    Fernández J; Ruiz del Arbol L; Gómez C; Durandez R; Serradilla R; Guarner C; Planas R; Arroyo V; Navasa M
    Gastroenterology; 2006 Oct; 131(4):1049-56; quiz 1285. PubMed ID: 17030175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parenteral antibiotic prophylaxis of bacterial infections does not improve cost-efficacy of oral norfloxacin in cirrhotic patients with gastrointestinal bleeding.
    Sàbat M; Kolle L; Soriano G; Ortiz J; Pamplona J; Novella MT; Villanueva C; Sainz S; Torras J; Balanzó J; Guarner C
    Am J Gastroenterol; 1998 Dec; 93(12):2457-62. PubMed ID: 9860409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infections caused by Escherichia coli resistant to norfloxacin in hospitalized cirrhotic patients.
    Ortiz J; Vila MC; Soriano G; Miñana J; Gana J; Mirelis B; Novella MT; Coll S; Sábat M; Andreu M; Prats G; Solá R; Guarner C
    Hepatology; 1999 Apr; 29(4):1064-9. PubMed ID: 10094947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of spontaneous Aeromonas bacterial peritonitis in cirrhotic patients: a matched case-control study.
    Choi JP; Lee SO; Kwon HH; Kwak YG; Choi SH; Lim SK; Kim MN; Jeong JY; Choi SH; Woo JH; Kim YS
    Clin Infect Dis; 2008 Jul; 47(1):66-72. PubMed ID: 18484880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance and outcome of nosocomial acquisition of spontaneous bacterial peritonitis in patients with liver cirrhosis.
    Cheong HS; Kang CI; Lee JA; Moon SY; Joung MK; Chung DR; Koh KC; Lee NY; Song JH; Peck KR
    Clin Infect Dis; 2009 May; 48(9):1230-6. PubMed ID: 19302016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized-controlled trial of rifaximin versus norfloxacin for secondary prophylaxis of spontaneous bacterial peritonitis.
    Elfert A; Abo Ali L; Soliman S; Ibrahim S; Abd-Elsalam S
    Eur J Gastroenterol Hepatol; 2016 Dec; 28(12):1450-1454. PubMed ID: 27512927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trimethoprim-sulfamethoxazole versus norfloxacin in the prophylaxis of spontaneous bacterial peritonitis in cirrhosis.
    Alvarez RF; Mattos AA; Corrêa EB; Cotrim HP; Nascimento TV
    Arq Gastroenterol; 2005; 42(4):256-62. PubMed ID: 16444382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ciprofloxacin in primary prophylaxis of spontaneous bacterial peritonitis: a randomized, placebo-controlled study.
    Terg R; Fassio E; Guevara M; Cartier M; Longo C; Lucero R; Landeira C; Romero G; Dominguez N; Muñoz A; Levi D; Miguez C; Abecasis R
    J Hepatol; 2008 May; 48(5):774-9. PubMed ID: 18316137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Primary prophylaxis of spontaneous bacterial peritonitis].
    Soriano G; Guarner C
    Gastroenterol Hepatol; 1997; 20(6):312-4. PubMed ID: 9296848
    [No Abstract]   [Full Text] [Related]  

  • 14. [Development of Escherichia coli strands resistant to quinolones in stools of patients with liver cirrhosis submitted to selective bowel decontamination].
    Aparicio JR; Such J; Gutiérrez A; Pérez-Mateo M; Plaza J; Arroyo A
    Med Clin (Barc); 1999 Sep; 113(7):241-5. PubMed ID: 10544377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term clinical outcome of large volume paracentesis with intravenous albumin in patients with spontaneous bacterial peritonitis: a randomized prospective study.
    Choi CH; Ahn SH; Kim DY; Lee SK; Park JY; Chon CY; Moon YM; Han KH
    J Gastroenterol Hepatol; 2005 Aug; 20(8):1215-22. PubMed ID: 16048569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-lasting NO overproduction in cirrhotic patients with spontaneous bacterial peritonitis.
    Bories PN; Campillo B; Azaou L; Scherman E
    Hepatology; 1997 Jun; 25(6):1328-33. PubMed ID: 9185747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites.
    Bajaj JS; Zadvornova Y; Heuman DM; Hafeezullah M; Hoffmann RG; Sanyal AJ; Saeian K
    Am J Gastroenterol; 2009 May; 104(5):1130-4. PubMed ID: 19337238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Norfloxacin modulates the inflammatory response and directly affects neutrophils in patients with decompensated cirrhosis.
    Zapater P; Caño R; Llanos L; Ruiz-Alcaraz AJ; Pascual S; Barquero C; Moreu R; Bellot P; Horga JF; Muñoz C; Pérez J; García-Peñarrubia P; Pérez-Mateo M; Such J; Francés R
    Gastroenterology; 2009 Nov; 137(5):1669-79.e1. PubMed ID: 19660462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of host and bacterial virulence factors in Escherichia coli spontaneous bacterial peritonitis.
    Cereto F; Herranz X; Moreno E; Andreu A; Vergara M; Fontanals D; Roget M; Simó M; González A; Prats G; Genescà J
    Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):924-9. PubMed ID: 18794608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cost analysis of long term antibiotic prophylaxis for spontaneous bacterial peritonitis in cirrhosis.
    Das A
    Am J Gastroenterol; 1998 Oct; 93(10):1895-900. PubMed ID: 9772051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.